✦ LIBER ✦

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs

✍ Scribed by Rohdich, Nadja (author);Roepke, Rainer Ka (author);Zschiesche, Eva (author)

Book ID: 125403511
Publisher: BioMed Central Ltd.
Year: 2014
Tongue: English
Weight: 181 KB
Volume: 7
Category: Article
ISSN: 1756-3305
DOI: 10.1186/1756-3305-7-83

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, blinded, controlled and mu

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs

✍ Rohdich, Nadja (author);Roepke, Rainer Ka (author);Zschiesche, Eva (author) 📂 Article 📅 2014 🏛 BioMed Central Ltd. 🌐 English ⚖ 181 KB

(751): A five-day, multi-center, randomi

(751): A five-day, multi-center, randomized, placebo-controlled, double-blind, efficacy and safety study of bicifadine and tramadol versus placebo in the treatment of postoperative bunionectomy pain

✍ D. Riff; N. Huang; P. Czobor; W. Stern 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Efficacy and safety of PG201 (Layla®) an

Efficacy and safety of PG201 (Layla®) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study

✍ Yoo, Wan-Hee; Yoo, Han-Gyul; Park, Sung-Hwan; Baek, Han-joo; Lee, Yun Jong; Shim 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 315 KB

46 A Phase 2a Randomized Placebo-Control

46 A Phase 2a Randomized Placebo-Controlled Double-Blind Multi-Center Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Patients With Moderately Active Ulcerative Colitis

✍ Severine Vermeire; Paul J. Rutgeerts; Geert R. D'Haens; Martine De Vos; Brian Br 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A phase 3, randomized, double-blind, pla

A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9months of treatment

✍ Mistry, Pramod; Lukina, Elena; Dridi, Marie-Françoise Ben; Amato, Dominick; Bari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

A PHASE 2, 8-WEEK, MULTI-CENTER, RANDOMI

A PHASE 2, 8-WEEK, MULTI-CENTER, RANDOMIZED DOUBLE- BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY EVALUATING THE EFFICACY, TOLERABILITY AND SAFETY OF [S,S] - REBOXETINE (PNU-165442G) FOR STRESS URINARY INCONTINENCE IN WOMEN

✍ Zinner, Norman; Scholfield, David; Soma, Koshika; Darekar, Amanda; Grant, Lee; M 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 149 KB